Page last updated: 2024-08-22

n-methylaspartate and budipine

n-methylaspartate has been researched along with budipine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobsen, P; Klockgether, T; Löschmann, PA; Turski, L1
Klockgether, T; Löschmann, PA; Petersen, V; Steinbach, JP; Turski, L; Wüllner, U1
Klockgether, T; Löschmann, PA; Spieker, S1
Müller, T1
Büttner, T; Csoti, I; Kassubek, J; Reichmann, H; Riederer, P; Schulz, JB; Wüllner, U1

Reviews

2 review(s) available for n-methylaspartate and budipine

ArticleYear
Non-dopaminergic drug treatment of Parkinson's disease.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:4

    Topics: Adenosine; Adrenergic alpha-Antagonists; Body Weight; Cholinergic Antagonists; Homocysteine; Humans; Levodopa; Methionine; N-Methylaspartate; Parkinson Disease; Piperidines; Serotonin Receptor Agonists

2001
[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease].
    Fortschritte der Neurologie-Psychiatrie, 2010, Volume: 78 Suppl 1

    Topics: Amantadine; Excitatory Amino Acid Antagonists; Humans; Indans; Memantine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methylaspartate; Parkinson Disease; Piperidines; Selegiline

2010

Trials

1 trial(s) available for n-methylaspartate and budipine

ArticleYear
The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3

    Topics: Adult; Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; N-Methylaspartate; Parkinson Disease; Pilot Projects; Piperidines; Severity of Illness Index

1999

Other Studies

2 other study(ies) available for n-methylaspartate and budipine

ArticleYear
The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist.
    Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 5, Issue:2

    Topics: Amino Acids; Anesthesia; Animals; Antiparkinson Agents; Binding, Competitive; Brain Chemistry; H-Reflex; In Vitro Techniques; Male; Mice; N-Methylaspartate; Phencyclidine; Piperidines; Rats; Receptors, N-Methyl-D-Aspartate; Reflex; Reflex, Monosynaptic; Seizures; Spinal Cord

1993
Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.
    European journal of pharmacology, 1996, Apr-22, Volume: 301, Issue:1-3

    Topics: Animals; Antiparkinson Agents; Biperiden; Central Nervous System; Dopamine; Excitatory Amino Acid Antagonists; Male; Mice; Microdialysis; Muscarinic Antagonists; N-Methylaspartate; Neostriatum; Neurotransmitter Agents; Oxidopamine; Piperazines; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Rotation; Seizures; Stereotyped Behavior; Sympatholytics

1996